TAMARA CAREY: Open Payments
NPI 1366991424 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 14 payments from 10 companies in 2025. Trend: 2023 $1,740 · 2024 $2,120 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $247 |
| Solventum Corporation | 3 | $183 |
| AngioDynamics, Inc. | 2 | $129 |
| Tempus AI, Inc | 1 | $125 |
| Intera Oncology, Inc | 1 | $123 |
| Alcresta Therapeutics, Inc. | 1 | $107 |
| Kite Pharma, Inc. | 1 | $107 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $89 |
| Gilead Sciences, Inc. | 1 | $68 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
Products named: V.A.C. VERAFLO, Padcev, NANOKNIFE, TEMPUS PIXEL, INTERA, Vyloy, RELIZORB, NERLYNX.
Industry payments across KY — which companies pay providers there.
